A carregar...
Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
Cisplatin (CDDP)-based combination chemotherapy remains the mainstream treatment for advanced bladder cancer. However, its efficacy is often limited due to the development of resistance for which underlying mechanisms are poorly understood. Meanwhile, emerging evidence has indicated the involvement...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226499/ https://ncbi.nlm.nih.gov/pubmed/27322140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9994 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|